Algert Global LLC Acquires Shares of 13,216 Trupanion, Inc. (NASDAQ:TRUP)

Algert Global LLC acquired a new stake in Trupanion, Inc. (NASDAQ:TRUP) during the fourth quarter, according to its most recent filing with the SEC. The firm acquired 13,216 shares of the financial services provider’s stock, valued at approximately $637,000.

Other hedge funds have also recently bought and sold shares of the company. Amundi boosted its position in Trupanion by 193.2% in the 4th quarter. Amundi now owns 16,828 shares of the financial services provider’s stock valued at $784,000 after buying an additional 11,088 shares during the last quarter. Barclays PLC boosted its position in Trupanion by 259.2% in the 3rd quarter. Barclays PLC now owns 65,498 shares of the financial services provider’s stock valued at $2,750,000 after buying an additional 47,262 shares during the last quarter. Vanguard Group Inc. boosted its position in Trupanion by 1.3% in the 4th quarter. Vanguard Group Inc. now owns 3,596,725 shares of the financial services provider’s stock valued at $173,362,000 after buying an additional 45,653 shares during the last quarter. Wealthfront Advisers LLC bought a new position in Trupanion in the 4th quarter valued at $845,000. Finally, Illinois Municipal Retirement Fund bought a new position in Trupanion in the 4th quarter valued at $834,000.

Analyst Ratings Changes

TRUP has been the topic of a number of recent research reports. Stifel Nicolaus decreased their price objective on Trupanion from $44.00 to $41.00 and set a “hold” rating on the stock in a research report on Thursday, February 20th. Lake Street Capital cut their price target on Trupanion from $65.00 to $60.00 and set a “buy” rating on the stock in a research note on Friday, May 2nd. Finally, Piper Sandler cut their price target on Trupanion from $57.00 to $52.00 and set an “overweight” rating on the stock in a research note on Thursday, February 20th. Two investment analysts have rated the stock with a hold rating, four have issued a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat.com, Trupanion presently has an average rating of “Moderate Buy” and a consensus target price of $51.80.

Insider Buying and Selling

In related news, CFO Fawwad Qureshi sold 1,373 shares of the firm’s stock in a transaction on Wednesday, February 26th. The stock was sold at an average price of $34.22, for a total transaction of $46,984.06. Following the sale, the chief financial officer now owns 2,416 shares of the company’s stock, valued at approximately $82,675.52. This trade represents a 36.24% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, CEO Margaret Tooth sold 2,294 shares of the firm’s stock in a transaction on Tuesday, March 4th. The stock was sold at an average price of $31.39, for a total value of $72,008.66. Following the sale, the chief executive officer now directly owns 118,784 shares in the company, valued at $3,728,629.76. The trade was a 1.89% decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders have sold 33,792 shares of company stock valued at $1,122,802. 5.50% of the stock is owned by company insiders.

Trupanion Stock Performance

TRUP stock opened at $44.31 on Monday. The business’s fifty day moving average is $36.70 and its 200-day moving average is $44.49. The company has a quick ratio of 1.66, a current ratio of 1.71 and a debt-to-equity ratio of 0.39. The company has a market cap of $1.90 billion, a P/E ratio of -192.65, a price-to-earnings-growth ratio of 6.02 and a beta of 1.72. Trupanion, Inc. has a twelve month low of $25.90 and a twelve month high of $57.90.

Trupanion (NASDAQ:TRUP) last posted its quarterly earnings results on Thursday, May 1st. The financial services provider reported ($0.03) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.05) by $0.02. The company had revenue of $341.98 million for the quarter, compared to the consensus estimate of $337.81 million. Trupanion had a negative return on equity of 3.08% and a negative net margin of 0.75%. The firm’s quarterly revenue was up 11.7% on a year-over-year basis. During the same quarter in the prior year, the business posted ($0.16) EPS. Equities research analysts forecast that Trupanion, Inc. will post 0.13 EPS for the current year.

About Trupanion

Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.